Common Contracts
2 similar Asset Sale and Purchase Agreement contracts by Cv Therapeutics Inc
EX-10.1 2 dex101.htm ASSET SALE AND PURCHASE AGREEMENT ASSET SALE AND PURCHASE AGREEMENTAsset Sale and Purchase Agreement • May 5th, 2020 • New York
This Asset Sale and Purchase Agreement (this “Agreement”) is entered into as of April 10, 2008, between CV Therapeutics, Inc., a Delaware corporation (“CVT”), and TPG-Axon Royalty Trust, a trust established under the laws of the Republic of Ireland (“TPG-Axon”). CVT and TPG-Axon are each referred to herein by name or, individually, as a “Party” or, collectively, as “Parties.” In addition, for purposes of this Agreement, the term “CVT” includes all successors and assignees of CVT’s rights and obligations under the Astellas Agreement (as defined below).
ASSET SALE AND PURCHASE AGREEMENTAsset Sale and Purchase Agreement • August 1st, 2008 • Cv Therapeutics Inc • Biological products, (no disgnostic substances) • New York
This Asset Sale and Purchase Agreement (this “Agreement”) is entered into as of April 10, 2008, between CV Therapeutics, Inc., a Delaware corporation (“CVT”), and TPG-Axon Royalty Trust, a trust established under the laws of the Republic of Ireland (“TPG-Axon”). CVT and TPG-Axon are each referred to herein by name or, individually, as a “Party” or, collectively, as “Parties.” In addition, for purposes of this Agreement, the term “CVT” includes all successors and assignees of CVT’s rights and obligations under the Astellas Agreement (as defined below).
